Graham Capital Management, L.P. Haemonetics Corp Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $404,144 - $484,190	-5,673 Reduced 44.81%	6,986 $596,000
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $1.02 Million - $1.17 Million	12,659 New	12,659 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $730,470 - $808,270	-9,036 Reduced 61.48%	5,662 $482,000
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $689,233 - $858,344	-9,474 Reduced 39.19%	14,698 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $754,303 - $879,833	10,214 Added 73.18%	24,172 $1.9 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $883,541 - $1.1 Million	13,958 New	13,958 $1.03 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.